课题基金 / 基金详情

项目摘要

项目成果

KUMAR SUBRAMANIAN的其他基金

相似基金

相关文献

中文摘要
翻译
项目总和 其专有名称包括Eskalith、Lithane、Lithonate、Lithobid和 另一些则以碳酸锂的形式给药,用于治疗躁郁症。 精神障碍(BD)、躁狂和躁郁症。锂的一个缺点是 治疗范围窄(0.4-1.2 mmol/L),需要治疗药物 监控。锂在血清、血浆、尿液或其他体液中的锂浓度 通过火焰发射光度法、原子吸收光谱法测定 或使用离子选择电极的电化学方法。血清分析,最有用的 用于锂监测的样品最常见的是通过自动量化 分光光度分析。然而,实验室程序复杂且时间长。 在消费。随着慢性病自我管理模式的发展,有越来越多的 需要为患者提供监测和管理其护理的工具。一个家- 基于锂水平的测试将为BD患者及其家人提供工具 定期监测他们的锂水平,并根据情况调整治疗 由他们的健康专家指导。 Y&Ijjf-of 项目叙事 随着慢性病自我管理模式的发展,人们越来越需要 为患者提供监控和管理其护理的工具。一种家用锂 Level测试将为BD患者及其家人提供工具来监控他们的 定期调整锂水平,并根据其指示相应调整治疗 健康专业人士。 V^^*7
英文摘要
PROJECT SUMIVIARY Lithium whose proprietary names include Eskalith, Lithane, Lithonate, Lithobid and others, is administered as lithium carbonate and used for treatment of the bipolar disorders (BD), mania, and manic-depressive illness. A disadvantage of lithium is the narrow therapeutic range (0.4 -1.2 mmol/L), which necessitates therapeutic drug monitoring. The concentration of lithium in serum, plasma, urine, or other body fluids have been determined by flame emission photometry, atomic absorption spectroscopy or electrochemically using ion-selective electrode. Serum analysis, the most useful specimen for lithium monitoring is most commonly quantified by automated spectrophotometric assay. However, the laboratory procedures are complex and time consuming. As chronic disease self-management models evolve, there is an increasing need to provide patients with the tools to monitor and manage their care. A home- based lithium level test would provide BD patients and their families with the tools to monitor their lithium levels on a regular basis and adjust treatment accordingly as directed by their health professional. Y&ijjf- Of PROJECT NARRATIVE As chronic disease self-management models evolve, there is an increasing need to provide patients with the tools to monitor and manage their care. A home-based lithium level test would provide BD patients and their families with the tools to monitor their lithium levels on a regular basis and adjust treatment accordingly as directed by their health professional. V^^*7
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID POINT OF CARE DIAGNOSTICS FOR HCV
  • 批准号:
    10497110
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
Low cost, automated smartphone based assay for semen analysis
  • 批准号:
    10028296
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
Multiplexed Point Of Care Nucleic Acid Assay for STI
  • 批准号:
    9074908
  • 项目类别:
  • 资助金额:
    $19.79万
  • 财政年份:
    2016
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
IGF::OT::IGFTitle: Multiplexed Biosensor for Detecting Low Abundance Cancer-rel
  • 批准号:
    8761949
  • 项目类别:
  • 资助金额:
    $99.98万
  • 财政年份:
    2013
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
国内基金
海外基金
NAD+/NADH Biosensor “智能”调控好氧/厌氧耦合供给NADH产氢研究
  • 批准号:
    31970038
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    赵洪新
  • 依托单位: